PTHLH and triple-negative breast carcinoma: A recent study reported that PTHrP inhibition reversed epithelial-to-mesenchymal transition (EMT) and diminished cancer stem cell populations in triple-negative breast cancer [19], further validating PTHrP as a critical driver of metastatic behavior.